Interview of leadXpro’s CEO Michael Hennig

European CEO, summer edition, 2018 (online)

Our CEO Michael Hennig was interviewed by the journal “European CEO”. In the Summer edition of 2018 a number of emerging CEOs from Europe based companies are introduced. Michael Hennig’s interview “Taking the lead” emphasizes facts about the core business of leadXpro, the impact of membrane proteins as drug targets and the key advantages leadXpro’s technologies provide to drug discovery and the creation of differentiating medicines.